Human Medicines Regulations 2012 · PART 1 General

8 General interpretation

reg. 8 Part 2 · in force: yes

Captured statutory text (L5)

8 General interpretation

(1)“MM medicinal product” means a medicinal product that, for reasons relating to deployment, the licensing authority determines it necessary or expedient to be manufactured or assembled in a modular unit;

(1)“modular unit” means a relocatable manufacturing unit;

(1)“naloxone product” means a medicinal product that contains naloxone or a salt, ester or stereoisomeric form of naloxone;

(1)“name” in relation to a medicinal product means—

(1)where the product has a UK marketing authorisation or traditional herbal registration, the name—

(1)as approved by the licensing authority in granting the authorisation or registration, or

(1)where that name has been varied since that approval, as so amended;

(1)... and

(1)where the product has an Article 126a authorisation, the name—

(1)as approved by the licensing authority to appear on the packaging and any package leaflet of the product under the authorisation, or

(1)where that name has been varied since that approval, as so amended;

(1)“the Narcotic Drugs Convention” means the Single Convention on Narcotic Drugs signed by the United Kingdom on 30thMarch 1961 as amended by the Protocol Amending the Single Convention on Narcotic Drugs signed by the United Kingdom on 25th March 1972;

(1)“NHS dispensing practice” means the business as part of which NHS pharmaceutical services are provided by general practitioners;

(1)“NHS pharmaceutical services” means—

(1)in England, pharmaceutical services under Part 7 of the National Health Service Act 2006;

(1)in Wales, pharmaceutical services under Part 7 of the National Health Service (Wales) Act 2006;

(1)in Scotland, pharmaceutical services under Part 2 of the National Health Service (Scotland) Act 1978;

(1)in Northern Ireland, pharmaceutical services under Part 6 of the Health and Personal Social Services (Northern Ireland) Order 1972;

(1)“NHS primary dental services” means—

(1)in relation to England, primary dental services under the National Health Service Act 2006;

(1)in relation to Wales, primary dental services under the National Health Service (Wales) Act 2006;

(1)in relation to Scotland, dental services under the National Health Service (Scotland) Act 1978 or personal dental services in connection with a pilot scheme under the National Health Service (Primary Care) Act 1997 ; and

(1)in relation to Northern Ireland, general dental services under the Health and Personal Social Services (Northern Ireland) Order 1972 or personal dental services in connection with a pilot scheme under the Health Services (Primary Care) (Northern Ireland) Order 1997 ;

(1)“NHS primary medical services” means—

(1)in relation to England, primary medical services under the National Health Service Act 2006;

(1)in relation to Wales, primary medical services under the National Health Service (Wales) Act 2006;

(1)in relation to Scotland, primary medical services under the National Health Service (Scotland) Act 1978; and

(1)in relation to Northern Ireland, primary medical services under the Health and Personal Social Services (Northern Ireland) Order 1972;

(1)“NIMAR” means Northern Ireland MHRA authorised route;

(1)“nurse independent prescriber” means a person who—

(1)is a registered nurse or registered midwife; and

(1)is noted in the professional register as qualified to order drugs, medicines and appliances as a nurse independent prescriber or a nurse independent / supplementary prescriber;

(1)“nursing home” has the meaning given by article 11 of the Health and Personal Social Services (Quality, Improvement and Regulation) (Northern Ireland) Order 2003;

(1)“occupational health vaccinator” means a person who is employed or engaged by a person operating an occupational health scheme, who is an individual belonging to one of the classes of individuals specified in Part 4 of Schedule 16;

(1)“optometrist independent prescriber” means a person—

(1)who is a registered optometrist; and

(1)against whose name is recorded in the relevant register an annotation signifying that the person is qualified to order drugs, medicines and appliances as an optometrist independent prescriber;

(1)“orphan criteria” means the criteria listed in regulation 50G(2);

(1)“orphan marketing authorisation” means a UK marketing authorisation granted under regulation 49(1)(a) in accordance with regulation 58C;

(1)“Orphan Regulation” means Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products as it has effect in EU law;

(1)“outer packaging” in relation to a medicinal product means any packaging into which the immediate packaging of the medicinal product is placed;

(1)“package” in relation to a medicinal product, includes—

(1)a container of the product;

(1)any box, packet or other article in which one or more containers of the product are or are to be enclosed; and

(1)any box, packet or other article in which a box, packet or other article mentioned in paragraph (b) or this paragraph is or is to be enclosed;

(1)“package leaflet” in relation to a medicinal product, means a leaflet that accompanies the product and contains information for the user of the product;

(1)“paediatric clinical trial” means a clinical trial conducted in whole or in part on persons under the age of 18 years;

(1)“paediatric indication” means a term of a UK marketing authorisation enabling the medicinal product to which the authorisation relates to be used by or administered to persons under the age of 18 years;

(1)“paediatric investigation plan” means a research and development programme with the purpose of generating data determining the conditions in which a medicinal product may be authorised to treat persons under the age of 18 years;

(1)“paediatric population” means that part of the population consisting of persons under the age of 18 years;

(1)“the Paediatric Regulation” means Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 ;

(1)“parallel import licence” has the meaning given in regulation 48(2);

(1)“paramedic independent prescriber” means a person—

(1)who is a registered paramedic; and

(1)against whose name is recorded in the relevant register an annotation signifying that the person is qualified to order drugs, medicines and appliances as a paramedic independent prescriber;

(1)“periodic safety update report” or “PSUR” has the meaning given in regulation 191 (obligation on holder to submit periodic safety update reports: general requirements);

(1)“pharmacist” means—

(1)in relation to Great Britain a person registered in Part 1 ... of the Register of pharmacists and pharmacy technicians maintained under article 19(2) of the Pharmacy Order 2010 ; and

(1)in relation to Northern Ireland a person registered in the register of pharmaceutical chemists for Northern Ireland ... maintained under articles 6 and 9 of the Pharmacy (Northern Ireland) Order 1976 ;

(1)“pharmacist independent prescriber” means a person who—

(1)is a pharmacist; and

(1)is noted in the relevant register as qualified to order drugs, medicines and appliances as a pharmacist independent prescriber;

(1)“the Pharmacovigilance Risk Assessment Committee” means the committee of the EMA established by Article 56(1)(aa) of Regulation (EC) No 726/2004;

(1)“pharmacovigilance system” means a system used by the holder of a UK marketing authorisation ..., traditional herbal registration or Article 126a authorisation, or by the licensing authority, to fulfil the tasks and responsibilities set out in Part 11 and designed to monitor the safety of authorised or registered medicinal products and detect any change to their risk-benefit balance;

(1)“pharmacovigilance system master file” means a detailed description of the pharmacovigilance system used by the holder of a UK marketing authorisation ..., traditional herbal registration or Article 126a authorisation with respect to one or more authorised or registered medicinal products;

(1)“pharmacy medicine” has the meaning given in regulation 5(5) (classification of medicinal products);

(1)“physiotherapist independent prescriber” means a person—

(1)who is a registered physiotherapist; and

(1)against whose name is recorded in the relevant register an annotation signifying that the person is qualified to order drugs, medicines and appliances as a physiotherapist independent prescriber;

(1)“POC” means point of care;

(1)“POC control site” means the premises at which the holder of a manufacturer’s licence (POC) supervises and controls the manufacture or assembly of POC medicinal products;

(1)“POC master file” means a detailed description of the arrangements for the manufacture or assembly of a POC medicinal product;

(1)“POC medicinal product” means a medicinal product that, for reasons relating to method of manufacture, shelf life, constituents or method or route of administration, can only be manufactured at or near the place where the product is to be used or administered;

(1)“POC site” means a site at which the manufacture or assembly of a POC medicinal product takes place;

(1)“podiatrist independent prescriber” means a person—

(1)who is a registered podiatrist; and

(1)against whose name is recorded in the relevant register an annotation signifying that the person is qualified to order drugs, medicines and appliances as a podiatrist independent prescriber;

(1)“post-authorisation efficacy study” means any study relating to a medicinal product to which a UK marketing authorisation relates that is conducted with the aim of considering the efficacy of that product;

(1)“post-authorisation safety study” means any study relating to a medicinal product to which a UK marketing authorisation ..., traditional herbal registration or Article 126a authorisation relates that is conducted with the aim of—

(1)identifying, characterising or quantifying a safety hazard;

(1)confirming the safety profile of the medicinal product; or

(1)measuring the effectiveness of risk management measures;

(1)“prescription only medicine” has the meaning given in regulation 5(3) (classification of medicinal products);

(1)“product information” in relation to a medicinal product means—

(1)the summary of the product characteristics;

(1)the immediate and outer packaging; and

(1)the package leaflet;

(1)“the professional register” means the register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001 ;

(1)“provider of probation services”—

(1)in England and Wales, has the same meaning as in Part 1 of the Offender Management Act 2007 (new arrangements for the provision of probation services); and

(1)in Northern Ireland, means the Probation Board for Northern Ireland;

(1)“provider of youth justice services” means—

(1)in England and Wales, a provider, other than a local authority, of the services specified in section 38(4) of the Crime and Disorder Act 1998 (local provision of youth justice services);

(1)in Scotland, a provider, other than a local authority, of the services in Scotland in respect of a child that most closely correspond to the services specified in section 38(4) of the Crime and Disorder Act 1998, and for these purposes “child” has the meaning given in section 199 of the Children’s Hearings (Scotland) Act 2011 (meaning of “child”); and

(1)in Northern Ireland, a body or other person with which or whom the Department of Justice has made arrangements for the provision of juvenile justice centres pursuant to Article 51(2) of the Criminal Justice (Children) (Northern Ireland) Order 1998 (juvenile justice centres);

(1)“the Psychotropic Substances Convention” means the Convention on Psychotropic Substances signed by the United Kingdom on 21st February 1971;

(1)“qualified person”, except in relation to the expression “appropriately qualified person”, means—

(1)a person who satisfies the requirements specified in Part 1 or 2 of Schedule 7; or

(1)where an application for a licence is made before 30th April 2013, in so far as the application relates to activities in respect of traditional herbal medicinal products, a person who has been engaged in activities in respect of traditional herbal medicinal products equivalent to those in Part 3 of Schedule 7 on or before 30th April 2011 and continues to be so engaged at the time when the application is made;

(1)“qualifying Northern Ireland goods” has the same meaning that it has in the European Union (Withdrawal) Act 2018, including any meaning defined for the purposes of that Act from time to time by regulations made under the power conferred by section 8C(6) of that Act;

(1)“radiation emergency” has the meaning given by regulation 2(1) of the Radiation (Emergency Preparedness and Public Information) Regulations 2019;

(1)“radionuclide” means a radioactive isotope;

(1)“radionuclide generator” means any system incorporating a fixed parent radionuclide from which is produced a daughter radionuclide which is to be removed by elution or by any other method and is to be used in a radiopharmaceutical;

(1)“radionuclide kit” means any preparation to be reconstituted or combined with radionuclides in the final radiopharmaceutical, usually prior to its administration;

(1)“radionuclide precursor” means any radionuclide produced for the radio-labelling of another substance prior to administration, other than a radionuclide that is incorporated in or produced from a generator or is included in a radiopharmaceutical;

(1)“radiopharmaceutical” means a medicinal product which, when ready for use, contains one or more radionuclides included for a medicinal purpose;

(1)“registered dietitian” means a person registered in Part 4 of the Health and Care Professions Council register;

(1)“registered midwife” means a person registered in the Midwives Part of the professional register;

(1)“registered nurse” means a person registered in the Nurses Part or the Specialist Community Public Health Nurses Part of the professional register;

(1)“registered optometrist” means a person whose name is entered in the register of optometrists maintained under section 7(a) of the Opticians Act 1989 ...;

(1)“registered paramedic” means a person who is registered in Part 8 of the Health and Care Professions Council register;

(1)“registered pharmacy” means—

(1)in relation to Great Britain, premises entered in the register required to be kept under article 19 of the Pharmacy Order 2010 for the purposes of sections 74A and 74J of the Medicines Act 1968 ; and

(1)in relation to Northern Ireland, premises entered in the register required to be kept under section 75 of the Medicines Act 1968;

(1)“registered physiotherapist” means a person registered in Part 9 of the Health and Care Professions Council register;

(1)“registered podiatrist” means a person registered in Part 2 of the Health and Care Professions Council register;

(1)“registered radiographer” means a person registered in Part 11 of the Health and Care Professions Council register;

(1)“registrable homoeopathic medicinal product” means a homoeopathic medicinal product to which regulation 102 applies;

(1)“Regulation (EC) No 726/2004” means Regulation (EC) 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency , as it has effect in EU law;

(1)...

(1)“Regulation (EC) No 1234/2008” means Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products , as it has effect in EU law;

(1)“the relevant EU provisions” means the provisions of legislation of the European Union relating to medicinal products for human use, except to the extent that any other enactment provides for any function in relation to any such provision to be exercised otherwise than by the licensing authority;

(1)“relevant European State” means an EEA State or Switzerland;

(1)“relevant medicinal product” has the meaning given by regulation 48;

(1)“the relevant register” means—

(1)in relation to a pharmacist—

(1)in Great Britain, Part 1 of the Register of pharmacists and pharmacy technicians maintained under article 19(2) of the Pharmacy Order 2010, or

(1)in Northern Ireland, the register maintained in pursuance of articles 6 and 9 of the Pharmacy (Northern Ireland) Order 1976;

(1)in relation to a registered nurse or registered midwife, the professional register;

(1)in relation to a registered optometrist, the register of optometrists maintained under section 7(a) of the Opticians Act 1989 ...; and

(1)in relation to a chiropodist or podiatrist, a physiotherapist, an orthoptist , a paramedic or a radiographer, the part of the Health and Care Professions Council register relating to—

(1)chiropodists and podiatrists,

(1)physiotherapists, ...

(1)radiographers, ...

(1)orthoptists , or

(1)paramedics;

(1)“retail pharmacy business” means a business (other than a professional practice carried on by a doctor , any other professional practice which is an NHS dispensing practice or a professional practice carried on by a dentist) which consists of or includes the retail sale of medicinal products that are not subject to general sale;

(1)“risk management plan” means a detailed description of the risk management system;

(1)“risk management system” means a set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to a medicinal product, including an assessment of the effectiveness of those activities and interventions;

(1)“serious adverse reaction” means an adverse reaction that—

(1)results in a person's death;

(1)threatens a person's life;

(1)results in a person being hospitalised as an inpatient or prolongs a person's existing stay in hospital;

(1)results in a person's persistent or significant disability or incapacity; or

(1)results in a congenital anomaly or birth defect;

(1)“special medicinal product” means a product within the meaning of regulation 167 or any equivalent legislation in a country other than the United Kingdom;

(1)“substance” means any matter regardless of its origins and includes—

(1)human substances (such as human blood and human blood products);

(1)animal substances (such as micro-organisms, whole animals, parts of organs, animal secretions, toxins, extracts and blood products);

(1)vegetable substances (such as micro-organisms, plants, parts of plants, vegetable secretions and extracts);

(1)chemical substances (such as elements, naturally occurring chemical materials and chemical products obtained by chemical change or synthesis); and

(1)gases and vapours;

(1)“the summary of the product characteristics” in relation to a medicinal product means—

(1)where the product has a UK marketing authorisation or traditional herbal registration, the summary of the product characteristics—

(1)as approved by the licensing authority in granting the authorisation or registration, or

(1)where the summary has been varied since that approval, as so amended; or

(1)where the product has an EU marketing authorisation, the summary of the product characteristics—

(1)as approved by the European Commission in granting the authorisation, or

(1)where the summary has been varied since that approval, as so amended;

(1)“supplementary prescriber” means a person who is noted in the relevant register as qualified to order drugs, medicines and appliances as a supplementary prescriber (or, in the case of a registered nurse or registered midwife, as a nurse independent/supplementary prescriber) and is—

(1)a pharmacist;

(1)a registered midwife;

(1)a registered nurse;

(1)a chiropodist, podiatrist, physiotherapist, paramedic or radiographer; ...

(1)a registered optometrist; or

(1)a registered dietitian;

(1)“supplementary protection certificate” has the meaning given in section 128B(2) of the Patents Act 1977;

(1)“suspected” in relation to an adverse reaction means that there is at least a reasonable possibility of there being a causal relationship between a medicinal product and an adverse event;

Full captured verbatim text

“MM medicinal product” means a medicinal product that, for reasons relating to deployment, the licensing authority determines it necessary or expedient to be manufactured or assembled in a modular unit;

“modular unit” means a relocatable manufacturing unit;

“naloxone product” means a medicinal product that contains naloxone or a salt, ester or stereoisomeric form of naloxone;

“name” in relation to a medicinal product means—

where the product has a UK marketing authorisation or traditional herbal registration, the name—

as approved by the licensing authority in granting the authorisation or registration, or

where that name has been varied since that approval, as so amended;

... and

where the product has an Article 126a authorisation, the name—

as approved by the licensing authority to appear on the packaging and any package leaflet of the product under the authorisation, or

where that name has been varied since that approval, as so amended;

“the Narcotic Drugs Convention” means the Single Convention on Narcotic Drugs signed by the United Kingdom on 30thMarch 1961 as amended by the Protocol Amending the Single Convention on Narcotic Drugs signed by the United Kingdom on 25th March 1972;

“NHS dispensing practice” means the business as part of which NHS pharmaceutical services are provided by general practitioners;

“NHS pharmaceutical services” means—

in England, pharmaceutical services under Part 7 of the National Health Service Act 2006;

in Wales, pharmaceutical services under Part 7 of the National Health Service (Wales) Act 2006;

in Scotland, pharmaceutical services under Part 2 of the National Health Service (Scotland) Act 1978;

in Northern Ireland, pharmaceutical services under Part 6 of the Health and Personal Social Services (Northern Ireland) Order 1972;

“NHS primary dental services” means—

in relation to England, primary dental services under the National Health Service Act 2006;

in relation to Wales, primary dental services under the National Health Service (Wales) Act 2006;

in relation to Scotland, dental services under the National Health Service (Scotland) Act 1978 or personal dental services in connection with a pilot scheme under the National Health Service (Primary Care) Act 1997 ; and

in relation to Northern Ireland, general dental services under the Health and Personal Social Services (Northern Ireland) Order 1972 or personal dental services in connection with a pilot scheme under the Health Services (Primary Care) (Northern Ireland) Order 1997 ;

“NHS primary medical services” means—

in relation to England, primary medical services under the National Health Service Act 2006;

in relation to Wales, primary medical services under the National Health Service (Wales) Act 2006;

in relation to Scotland, primary medical services under the National Health Service (Scotland) Act 1978; and

in relation to Northern Ireland, primary medical services under the Health and Personal Social Services (Northern Ireland) Order 1972;

“NIMAR” means Northern Ireland MHRA authorised route;

“nurse independent prescriber” means a person who—

is a registered nurse or registered midwife; and

is noted in the professional register as qualified to order drugs, medicines and appliances as a nurse independent prescriber or a nurse independent / supplementary prescriber;

“nursing home” has the meaning given by article 11 of the Health and Personal Social Services (Quality, Improvement and Regulation) (Northern Ireland) Order 2003;

“occupational health vaccinator” means a person who is employed or engaged by a person operating an occupational health scheme, who is an individual belonging to one of the classes of individuals specified in Part 4 of Schedule 16;

“optometrist independent prescriber” means a person—

who is a registered optometrist; and

against whose name is recorded in the relevant register an annotation signifying that the person is qualified to order drugs, medicines and appliances as an optometrist independent prescriber;

“orphan criteria” means the criteria listed in regulation 50G(2);

“orphan marketing authorisation” means a UK marketing authorisation granted under regulation 49(1)(a) in accordance with regulation 58C;

“Orphan Regulation” means Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products as it has effect in EU law;

“outer packaging” in relation to a medicinal product means any packaging into which the immediate packaging of the medicinal product is placed;

“package” in relation to a medicinal product, includes—

a container of the product;

any box, packet or other article in which one or more containers of the product are or are to be enclosed; and

any box, packet or other article in which a box, packet or other article mentioned in paragraph (b) or this paragraph is or is to be enclosed;

“package leaflet” in relation to a medicinal product, means a leaflet that accompanies the product and contains information for the user of the product;

“paediatric clinical trial” means a clinical trial conducted in whole or in part on persons under the age of 18 years;

“paediatric indication” means a term of a UK marketing authorisation enabling the medicinal product to which the authorisation relates to be used by or administered to persons under the age of 18 years;

“paediatric investigation plan” means a research and development programme with the purpose of generating data determining the conditions in which a medicinal product may be authorised to treat persons under the age of 18 years;

“paediatric population” means that part of the population consisting of persons under the age of 18 years;

“the Paediatric Regulation” means Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 ;

“parallel import licence” has the meaning given in regulation 48(2);

“paramedic independent prescriber” means a person—

who is a registered paramedic; and

against whose name is recorded in the relevant register an annotation signifying that the person is qualified to order drugs, medicines and appliances as a paramedic independent prescriber;

“periodic safety update report” or “PSUR” has the meaning given in regulation 191 (obligation on holder to submit periodic safety update reports: general requirements);

“pharmacist” means—

in relation to Great Britain a person registered in Part 1 ... of the Register of pharmacists and pharmacy technicians maintained under article 19(2) of the Pharmacy Order 2010 ; and

in relation to Northern Ireland a person registered in the register of pharmaceutical chemists for Northern Ireland ... maintained under articles 6 and 9 of the Pharmacy (Northern Ireland) Order 1976 ;

“pharmacist independent prescriber” means a person who—

is a pharmacist; and

is noted in the relevant register as qualified to order drugs, medicines and appliances as a pharmacist independent prescriber;

“the Pharmacovigilance Risk Assessment Committee” means the committee of the EMA established by Article 56(1)(aa) of Regulation (EC) No 726/2004;

“pharmacovigilance system” means a system used by the holder of a UK marketing authorisation ..., traditional herbal registration or Article 126a authorisation, or by the licensing authority, to fulfil the tasks and responsibilities set out in Part 11 and designed to monitor the safety of authorised or registered medicinal products and detect any change to their risk-benefit balance;

“pharmacovigilance system master file” means a detailed description of the pharmacovigilance system used by the holder of a UK marketing authorisation ..., traditional herbal registration or Article 126a authorisation with respect to one or more authorised or registered medicinal products;

“pharmacy medicine” has the meaning given in regulation 5(5) (classification of medicinal products);

“physiotherapist independent prescriber” means a person—

who is a registered physiotherapist; and

against whose name is recorded in the relevant register an annotation signifying that the person is qualified to order drugs, medicines and appliances as a physiotherapist independent prescriber;

“POC” means point of care;

“POC control site” means the premises at which the holder of a manufacturer’s licence (POC) supervises and controls the manufacture or assembly of POC medicinal products;

“POC master file” means a detailed description of the arrangements for the manufacture or assembly of a POC medicinal product;

“POC medicinal product” means a medicinal product that, for reasons relating to method of manufacture, shelf life, constituents or method or route of administration, can only be manufactured at or near the place where the product is to be used or administered;

“POC site” means a site at which the manufacture or assembly of a POC medicinal product takes place;

“podiatrist independent prescriber” means a person—

who is a registered podiatrist; and

against whose name is recorded in the relevant register an annotation signifying that the person is qualified to order drugs, medicines and appliances as a podiatrist independent prescriber;

“post-authorisation efficacy study” means any study relating to a medicinal product to which a UK marketing authorisation relates that is conducted with the aim of considering the efficacy of that product;

“post-authorisation safety study” means any study relating to a medicinal product to which a UK marketing authorisation ..., traditional herbal registration or Article 126a authorisation relates that is conducted with the aim of—

identifying, characterising or quantifying a safety hazard;

confirming the safety profile of the medicinal product; or

measuring the effectiveness of risk management measures;

“prescription only medicine” has the meaning given in regulation 5(3) (classification of medicinal products);

“product information” in relation to a medicinal product means—

the summary of the product characteristics;

the immediate and outer packaging; and

the package leaflet;

“the professional register” means the register maintained by the Nursing and Midwifery Council under article 5 of the Nursing and Midwifery Order 2001 ;

“provider of probation services”—

in England and Wales, has the same meaning as in Part 1 of the Offender Management Act 2007 (new arrangements for the provision of probation services); and

in Northern Ireland, means the Probation Board for Northern Ireland;

“provider of youth justice services” means—

in England and Wales, a provider, other than a local authority, of the services specified in section 38(4) of the Crime and Disorder Act 1998 (local provision of youth justice services);

in Scotland, a provider, other than a local authority, of the services in Scotland in respect of a child that most closely correspond to the services specified in section 38(4) of the Crime and Disorder Act 1998, and for these purposes “child” has the meaning given in section 199 of the Children’s Hearings (Scotland) Act 2011 (meaning of “child”); and

in Northern Ireland, a body or other person with which or whom the Department of Justice has made arrangements for the provision of juvenile justice centres pursuant to Article 51(2) of the Criminal Justice (Children) (Northern Ireland) Order 1998 (juvenile justice centres);

“the Psychotropic Substances Convention” means the Convention on Psychotropic Substances signed by the United Kingdom on 21st February 1971;

“qualified person”, except in relation to the expression “appropriately qualified person”, means—

a person who satisfies the requirements specified in Part 1 or 2 of Schedule 7; or

where an application for a licence is made before 30th April 2013, in so far as the application relates to activities in respect of traditional herbal medicinal products, a person who has been engaged in activities in respect of traditional herbal medicinal products equivalent to those in Part 3 of Schedule 7 on or before 30th April 2011 and continues to be so engaged at the time when the application is made;

“qualifying Northern Ireland goods” has the same meaning that it has in the European Union (Withdrawal) Act 2018, including any meaning defined for the purposes of that Act from time to time by regulations made under the power conferred by section 8C(6) of that Act;

“radiation emergency” has the meaning given by regulation 2(1) of the Radiation (Emergency Preparedness and Public Information) Regulations 2019;

“radionuclide” means a radioactive isotope;

“radionuclide generator” means any system incorporating a fixed parent radionuclide from which is produced a daughter radionuclide which is to be removed by elution or by any other method and is to be used in a radiopharmaceutical;

“radionuclide kit” means any preparation to be reconstituted or combined with radionuclides in the final radiopharmaceutical, usually prior to its administration;

“radionuclide precursor” means any radionuclide produced for the radio-labelling of another substance prior to administration, other than a radionuclide that is incorporated in or produced from a generator or is included in a radiopharmaceutical;

“radiopharmaceutical” means a medicinal product which, when ready for use, contains one or more radionuclides included for a medicinal purpose;

“registered dietitian” means a person registered in Part 4 of the Health and Care Professions Council register;

“registered midwife” means a person registered in the Midwives Part of the professional register;

“registered nurse” means a person registered in the Nurses Part or the Specialist Community Public Health Nurses Part of the professional register;

“registered optometrist” means a person whose name is entered in the register of optometrists maintained under section 7(a) of the Opticians Act 1989 ...;

“registered paramedic” means a person who is registered in Part 8 of the Health and Care Professions Council register;

“registered pharmacy” means—

in relation to Great Britain, premises entered in the register required to be kept under article 19 of the Pharmacy Order 2010 for the purposes of sections 74A and 74J of the Medicines Act 1968 ; and

in relation to Northern Ireland, premises entered in the register required to be kept under section 75 of the Medicines Act 1968;

“registered physiotherapist” means a person registered in Part 9 of the Health and Care Professions Council register;

“registered podiatrist” means a person registered in Part 2 of the Health and Care Professions Council register;

“registered radiographer” means a person registered in Part 11 of the Health and Care Professions Council register;

“registrable homoeopathic medicinal product” means a homoeopathic medicinal product to which regulation 102 applies;

“Regulation (EC) No 726/2004” means Regulation (EC) 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency , as it has effect in EU law;

...

“Regulation (EC) No 1234/2008” means Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products , as it has effect in EU law;

“the relevant EU provisions” means the provisions of legislation of the European Union relating to medicinal products for human use, except to the extent that any other enactment provides for any function in relation to any such provision to be exercised otherwise than by the licensing authority;

“relevant European State” means an EEA State or Switzerland;

“relevant medicinal product” has the meaning given by regulation 48;

“the relevant register” means—

in relation to a pharmacist—

in Great Britain, Part 1 of the Register of pharmacists and pharmacy technicians maintained under article 19(2) of the Pharmacy Order 2010, or

in Northern Ireland, the register maintained in pursuance of articles 6 and 9 of the Pharmacy (Northern Ireland) Order 1976;

in relation to a registered nurse or registered midwife, the professional register;

in relation to a registered optometrist, the register of optometrists maintained under section 7(a) of the Opticians Act 1989 ...; and

in relation to a chiropodist or podiatrist, a physiotherapist, an orthoptist , a paramedic or a radiographer, the part of the Health and Care Professions Council register relating to—

chiropodists and podiatrists,

physiotherapists, ...

radiographers, ...

orthoptists , or

paramedics;

“retail pharmacy business” means a business (other than a professional practice carried on by a doctor , any other professional practice which is an NHS dispensing practice or a professional practice carried on by a dentist) which consists of or includes the retail sale of medicinal products that are not subject to general sale;

“risk management plan” means a detailed description of the risk management system;

“risk management system” means a set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to a medicinal product, including an assessment of the effectiveness of those activities and interventions;

“serious adverse reaction” means an adverse reaction that—

results in a person's death;

threatens a person's life;

results in a person being hospitalised as an inpatient or prolongs a person's existing stay in hospital;

results in a person's persistent or significant disability or incapacity; or

results in a congenital anomaly or birth defect;

“special medicinal product” means a product within the meaning of regulation 167 or any equivalent legislation in a country other than the United Kingdom;

“substance” means any matter regardless of its origins and includes—

human substances (such as human blood and human blood products);

animal substances (such as micro-organisms, whole animals, parts of organs, animal secretions, toxins, extracts and blood products);

vegetable substances (such as micro-organisms, plants, parts of plants, vegetable secretions and extracts);

chemical substances (such as elements, naturally occurring chemical materials and chemical products obtained by chemical change or synthesis); and

gases and vapours;

“the summary of the product characteristics” in relation to a medicinal product means—

where the product has a UK marketing authorisation or traditional herbal registration, the summary of the product characteristics—

as approved by the licensing authority in granting the authorisation or registration, or

where the summary has been varied since that approval, as so amended; or

where the product has an EU marketing authorisation, the summary of the product characteristics—

as approved by the European Commission in granting the authorisation, or

where the summary has been varied since that approval, as so amended;

“supplementary prescriber” means a person who is noted in the relevant register as qualified to order drugs, medicines and appliances as a supplementary prescriber (or, in the case of a registered nurse or registered midwife, as a nurse independent/supplementary prescriber) and is—

a pharmacist;

a registered midwife;

a registered nurse;

a chiropodist, podiatrist, physiotherapist, paramedic or radiographer; ...

a registered optometrist; or

a registered dietitian;

“supplementary protection certificate” has the meaning given in section 128B(2) of the Patents Act 1977;

“suspected” in relation to an adverse reaction means that there is at least a reasonable possibility of there being a causal relationship between a medicinal product and an adverse event;

What this provision means

Model summary, checked against the text on the left.

Relevance to Signicat: 1/3 · detailed summary (L4) Status: not needed for a short provision · Stored artifact; current recipe verification unavailable

General interpretation definitions establish terms for manufacturing models, prescriptions, healthcare registers, and pharmacovigilance.

Only the one-line summary above is stored for this provision; the text itself is the evidence.

Refers to

No captured references.

Referred to by

No captured references.

Part summaries

0 of 0 parts have a verified summary.

L1 unavailable for current verification: the overall summary needs every part verified. Provisions and the verified summaries remain readable.

Verification findings (1458)

synthesis coverage: missing/unverified L2 part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-2A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-3A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-8-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-8-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-8-part-3

synthesis coverage: missing/unverified L2 part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-16

synthesis coverage: missing/unverified L2 part-3-chapter-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-A17

synthesis coverage: missing/unverified L2 part-3-chapter-1A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-B17

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-C17

synthesis coverage: missing/unverified L2 part-3-chapter-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-17A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-17B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-18A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-25

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-27

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-27A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-29A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-29B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-30

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-31

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-32

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-33

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-34

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-35

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-36

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-37

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-37A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-37B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-38

synthesis coverage: missing/unverified L2 part-3-chapter-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-39

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-40

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-41

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-42

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-43

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-43ZA

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-43A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-44

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45AA

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45AB

synthesis coverage: missing/unverified L2 part-3-chapter-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45D

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45E

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45F

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45G

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45H

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45I

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45J

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45K

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45L

synthesis coverage: missing/unverified L2 part-3-chapter-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45M

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45N

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45O

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45P

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45Q

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45R

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45S

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45T

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45U

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-45V

synthesis coverage: missing/unverified L2 part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-46

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-47

synthesis coverage: missing/unverified L2 part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-48

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-49

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50D

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50E

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50F

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50G

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50H

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50I

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50J

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-50K

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-51

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-51A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-51B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-52

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-52A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-52B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-53

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-53A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-53B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-54

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-55

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-56

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-57

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-57A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-58

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-58A

synthesis coverage: missing/unverified L2 part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-58B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-58C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-58D

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-58E

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-58F

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-58G

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-59

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-60

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-60A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-60B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-61

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-62

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-63

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-64

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-64A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-65

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-65A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-65B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-65C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-66

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-66A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-66B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-67

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-68

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-69

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-70

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-71

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-72

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-73

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-74

synthesis coverage: missing/unverified L2 part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-74A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-74B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-75

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-76

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-77

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-78

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-78A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-78B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-79

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-80

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-80A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-A81

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-81

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-82

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-83

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-84

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-85

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-86

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-87

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-88

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-89

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-90

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-91

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-92

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-93

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-94

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-94A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-95

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-95A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-96

synthesis coverage: missing/unverified L2 part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-97

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-98

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-99

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-100

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-101

synthesis coverage: missing/unverified L2 part-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-102

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-103

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-104

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-105

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-106

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-107

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-108

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-109

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-110

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-111

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-112

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-113

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-114

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-115

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-116

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-117

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-118

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-119

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-120

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-121

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-122

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-123

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-124

synthesis coverage: missing/unverified L2 part-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-124A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-125

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-125A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-126

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-126A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-127

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-128

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-129

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-130

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-130A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-131

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-132

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-133

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-134

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-135

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-136

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-137

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-138

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-139

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-140

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-141

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-142

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-143

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-143A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-144

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-145

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-146

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-147

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-148

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-148A

synthesis coverage: missing/unverified L2 part-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-149

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-150

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-151

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-152

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-153

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-154

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-155

synthesis coverage: missing/unverified L2 part-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-156

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-157

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-158

synthesis coverage: missing/unverified L2 part-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-159

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-160

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-161

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-162

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-163

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-164

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-165

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-166

synthesis coverage: missing/unverified L2 part-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167D

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167E

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167F

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167G

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-167H

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-168

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-169

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-170

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-170A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-170B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-171

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-172

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-173

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-174

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-174A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-175

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-176

synthesis coverage: missing/unverified L2 part-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-177

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-178

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-179

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-180

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-181

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-182

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-183

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-184

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-185

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-186

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-186A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-187

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-188

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-189

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-190

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-191

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-191A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-192

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-193

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-194

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-195

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-196

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-196A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-197

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-198

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-199

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-200

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-201

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-202

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-202A

synthesis coverage: missing/unverified L2 part-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-203

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-204

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-205

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-205A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-205B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-206

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-207

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-208

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-209

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-210

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-210A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-211

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-212

synthesis coverage: missing/unverified L2 part-12-chapter-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-213

synthesis coverage: missing/unverified L2 part-12-chapter-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-214

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-215

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-216

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-217

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-217A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-217B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-217BA

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-217C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-217CA

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-218

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-219

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-219A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-220

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-220B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-221

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-222

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-222A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-222B

synthesis coverage: missing/unverified L2 part-12-chapter-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-223

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-224

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-225

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-226

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-226A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-227

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-228

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-229

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-230

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-231

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-232

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-233

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-234

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-235

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-235A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-236

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-237

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-237A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-238

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-239

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-240

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-241

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-242

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-243

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-244

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-245

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-246

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-247

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-247A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-248

synthesis coverage: missing/unverified L2 part-12-chapter-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-249

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-250

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-251

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-252

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-253

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-254

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-255

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-255A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-255B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-255C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256

synthesis coverage: missing/unverified L2 part-12A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256ZA

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256D

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256E

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256F

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256G

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256H

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256I

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256J

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256K

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256L

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256M

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-256N

synthesis coverage: missing/unverified L2 part-13-chapter-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257AA

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257AB

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257C

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257CA

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257D

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-257E

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-258

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-259

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-260

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-261

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-262

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-263

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-264

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-265

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-266

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-267

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-268

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-268A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-269

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-269A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-270

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-271

synthesis coverage: missing/unverified L2 part-13-chapter-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-272

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-273

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-274

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-275

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-276

synthesis coverage: missing/unverified L2 part-14-chapter-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-277

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-278

synthesis coverage: missing/unverified L2 part-14-chapter-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-279

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-280

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-281

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-282

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-283

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-284

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-284A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-285

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-286

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-287

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-288

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-289

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-290

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-291

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-291A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-292

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-293

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-294

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-295

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-296

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-297

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-298

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-299

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-300

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-301

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-302

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-303

synthesis coverage: missing/unverified L2 part-14-chapter-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-304

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-305

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-306

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-307

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-308

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-309

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-310

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-311

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-312

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-313

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-314

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-315

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-316

synthesis coverage: missing/unverified L2 part-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-317

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-318

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-319

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-320

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-321

synthesis coverage: missing/unverified L2 part-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-322

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-323

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-324

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-325

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-326

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-327

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-328

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-329

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-330

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-331

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-331A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-332

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-333

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-334

synthesis coverage: missing/unverified L2 part-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-335

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-336

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-337

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-338

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-339

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-340

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-341

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-342

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-343

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-344

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-344A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-344B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-345

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-345A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-346

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-347

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-347A

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-347B

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-348

synthesis coverage: missing evaluation uk:uksi/2012/1916#regulation-349

synthesis coverage: missing/unverified L2 schedule-1-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-1-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-1-paragraph-2

synthesis coverage: missing/unverified L2 schedule-1-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-1-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-1-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-1-paragraph-5

synthesis coverage: missing/unverified L2 schedule-2-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-4

synthesis coverage: missing/unverified L2 schedule-2-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-7

synthesis coverage: missing/unverified L2 schedule-2-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-11

synthesis coverage: missing/unverified L2 schedule-2-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-2-paragraph-12

synthesis coverage: missing/unverified L2 schedule-3-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-3-paragraph-1

synthesis coverage: missing/unverified L2 schedule-3-part-2n1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-3-paragraph-1A

synthesis coverage: missing/unverified L2 schedule-3-part-3n1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-3-paragraph-1B

synthesis coverage: missing/unverified L2 schedule-3-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-3-paragraph-2

synthesis coverage: missing/unverified L2 schedule-3-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-3-paragraph-3

synthesis coverage: missing/unverified L2 schedule-3-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-3-paragraph-4

synthesis coverage: missing/unverified L2 schedule-4-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14B

synthesis coverage: missing/unverified L2 schedule-4-part-1A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14C

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14D

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14E

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14F

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14G

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14H

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14I

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14J

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14K

synthesis coverage: missing/unverified L2 schedule-4-part-1B

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14L

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14M

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14N

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14O

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14P

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14Q

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14R

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14S

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-14T

synthesis coverage: missing/unverified L2 schedule-4-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-15A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-23ZA

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-23A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-23B

synthesis coverage: missing/unverified L2 schedule-4-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-27

synthesis coverage: missing/unverified L2 schedule-4-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-33A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-35

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-36

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-37

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-38

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-39

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-40

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-41

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-41A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-42

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-43

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-4-paragraph-44

synthesis coverage: missing/unverified L2 schedule-5-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-5-paragraph-1

synthesis coverage: missing/unverified L2 schedule-5-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-5-paragraph-2

synthesis coverage: missing/unverified L2 schedule-5-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-5-paragraph-3

synthesis coverage: missing/unverified L2 schedule-5-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-5-paragraph-4

synthesis coverage: missing/unverified L2 schedule-5-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-5-paragraph-5

synthesis coverage: missing/unverified L2 schedule-6-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-12

synthesis coverage: missing/unverified L2 schedule-6-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-6-paragraph-20

synthesis coverage: missing/unverified L2 schedule-7-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-8

synthesis coverage: missing/unverified L2 schedule-7-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-11

synthesis coverage: missing/unverified L2 schedule-7-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-12A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-12B

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7-paragraph-15

synthesis coverage: missing/unverified L2 schedule-7A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-7A-paragraph-24

synthesis coverage: missing/unverified L2 schedule-8-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-9A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-22

synthesis coverage: missing/unverified L2 schedule-8-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-25A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-35

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8-paragraph-36

synthesis coverage: missing/unverified L2 schedule-8A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8A-paragraph-9

synthesis coverage: missing/unverified L2 schedule-8C

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8C-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8C-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-8C-paragraph-3

synthesis coverage: missing/unverified L2 schedule-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9-paragraph-12

synthesis coverage: missing/unverified L2 schedule-9A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-9A-paragraph-8

synthesis coverage: missing/unverified L2 schedule-10-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10-paragraph-1

synthesis coverage: missing/unverified L2 schedule-10-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10-paragraph-2

synthesis coverage: missing/unverified L2 schedule-10-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10-paragraph-3

synthesis coverage: missing/unverified L2 schedule-10-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10-paragraph-4

synthesis coverage: missing/unverified L2 schedule-10-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10-paragraph-5

synthesis coverage: missing/unverified L2 schedule-10A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-10A-paragraph-17

synthesis coverage: missing/unverified L2 schedule-11-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-13

synthesis coverage: missing/unverified L2 schedule-11-part-1A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-13A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-13B

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-13C

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-13D

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-13E

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-13F

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-13G

synthesis coverage: missing/unverified L2 schedule-11-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-23

synthesis coverage: missing/unverified L2 schedule-11-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-30

synthesis coverage: missing/unverified L2 schedule-11-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-35

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-36

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-37

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-38

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-11-paragraph-39

synthesis coverage: missing/unverified L2 schedule-12-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-20

synthesis coverage: missing/unverified L2 schedule-12-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12-paragraph-30

synthesis coverage: missing/unverified L2 schedule-12A-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-7

synthesis coverage: missing/unverified L2 schedule-12A-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-9

synthesis coverage: missing/unverified L2 schedule-12A-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-13

synthesis coverage: missing/unverified L2 schedule-12A-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-17

synthesis coverage: missing/unverified L2 schedule-12A-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-18

synthesis coverage: missing/unverified L2 schedule-12A-part-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-21

synthesis coverage: missing/unverified L2 schedule-12A-part-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-25

synthesis coverage: missing/unverified L2 schedule-12A-part-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-27

synthesis coverage: missing/unverified L2 schedule-12A-part-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-12A-paragraph-32

synthesis coverage: missing/unverified L2 schedule-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-15-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-15-paragraph-2

synthesis coverage: missing/unverified L2 schedule-16-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-16-paragraph-17

synthesis coverage: missing/unverified L2 schedule-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-23-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-23-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-23-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-23-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-23-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-23-paragraph-6

synthesis coverage: missing/unverified L2 schedule-24-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-18A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-18B

synthesis coverage: missing/unverified L2 schedule-24-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-25

synthesis coverage: missing/unverified L2 schedule-24-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-33

synthesis coverage: missing/unverified L2 schedule-24-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-35

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-36

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-37

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-38

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-39

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-40

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-41

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-42

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-43

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-44

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-45

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-46

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-47

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-48

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-49

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-50

synthesis coverage: missing/unverified L2 schedule-24-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-51

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-52

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-53

synthesis coverage: missing/unverified L2 schedule-24-part-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-54

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-55

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-56

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-57

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-58

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-59

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-60

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-61

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-62

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-63

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-64

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-65

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-66

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-67

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-68

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-69

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-70

synthesis coverage: missing/unverified L2 schedule-24-part-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-71

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-72

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-73

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-74

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-75

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-76

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-77

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-78

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-79

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-24-paragraph-80

synthesis coverage: missing/unverified L2 schedule-25-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-6A

synthesis coverage: missing/unverified L2 schedule-25-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-9

synthesis coverage: missing/unverified L2 schedule-25-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-13

synthesis coverage: missing/unverified L2 schedule-25-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-25-paragraph-18

synthesis coverage: missing/unverified L2 schedule-26-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-4A

synthesis coverage: missing/unverified L2 schedule-26-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-10A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-26-paragraph-11

synthesis coverage: missing/unverified L2 schedule-27-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-15

synthesis coverage: missing/unverified L2 schedule-27-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-17

synthesis coverage: missing/unverified L2 schedule-27-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-27-paragraph-30

synthesis coverage: missing/unverified L2 schedule-28-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-12

synthesis coverage: missing/unverified L2 schedule-28-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-17

synthesis coverage: missing/unverified L2 schedule-28-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-28-paragraph-24

synthesis coverage: missing/unverified L2 schedule-29-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-29-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-29-paragraph-2

synthesis coverage: missing/unverified L2 schedule-29-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-29-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-29-paragraph-4

synthesis coverage: missing/unverified L2 schedule-30

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-2A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-30-paragraph-9

synthesis coverage: missing/unverified L2 schedule-31-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-1

synthesis coverage: missing/unverified L2 schedule-31-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-13

synthesis coverage: missing/unverified L2 schedule-31-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-14

synthesis coverage: missing/unverified L2 schedule-31-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-20

synthesis coverage: missing/unverified L2 schedule-31-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-23

synthesis coverage: missing/unverified L2 schedule-31-part-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-25

synthesis coverage: missing/unverified L2 schedule-31-part-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-26

synthesis coverage: missing/unverified L2 schedule-31-part-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-31-paragraph-27

synthesis coverage: missing/unverified L2 schedule-32-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-32-paragraph-1

synthesis coverage: missing/unverified L2 schedule-32-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-32-paragraph-2

synthesis coverage: missing/unverified L2 schedule-32-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-32-paragraph-3

synthesis coverage: missing/unverified L2 schedule-32-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-32-paragraph-4

synthesis coverage: missing/unverified L2 schedule-32-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-32-paragraph-5

synthesis coverage: missing/unverified L2 schedule-32-part-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-32-paragraph-6

synthesis coverage: missing/unverified L2 schedule-32-part-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-32-paragraph-7

synthesis coverage: missing/unverified L2 schedule-33

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33-paragraph-10

synthesis coverage: missing/unverified L2 schedule-33A-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-1

synthesis coverage: missing/unverified L2 schedule-33A-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-5

synthesis coverage: missing/unverified L2 schedule-33A-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-25

synthesis coverage: missing/unverified L2 schedule-33A-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-26ZA

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-27A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-29A

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-30

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-35

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-36

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-37

synthesis coverage: missing/unverified L2 schedule-33A-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-38

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-39

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-40

synthesis coverage: missing/unverified L2 schedule-33A-part-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-41

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-41A

synthesis coverage: missing/unverified L2 schedule-33A-part-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-43

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-44

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-45

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-46

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-47

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-48

synthesis coverage: missing/unverified L2 schedule-33A-part-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-49

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-50

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-51

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-52

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-53

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-54

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-55

synthesis coverage: missing/unverified L2 schedule-33A-part-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-58

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-59

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-60

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-61

synthesis coverage: missing/unverified L2 schedule-33A-part-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-62

synthesis coverage: missing/unverified L2 schedule-33A-part-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33A-paragraph-63

synthesis coverage: missing/unverified L2 schedule-33B

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33B-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33B-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-33B-paragraph-3

synthesis coverage: missing/unverified L2 schedule-34-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-27

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-28

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-29

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-30

synthesis coverage: missing/unverified L2 schedule-34-part-1

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-31

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-32

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-33

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-34

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-35

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-36

synthesis coverage: missing/unverified L2 schedule-34-part-2

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-37

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-38

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-39

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-40

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-41

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-42

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-43

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-44

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-45

synthesis coverage: missing/unverified L2 schedule-34-part-3

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-46

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-47

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-48

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-49

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-50

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-51

synthesis coverage: missing/unverified L2 schedule-34-part-4

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-52

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-53

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-54

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-55

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-56

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-57

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-58

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-59

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-60

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-61

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-62

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-63

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-64

synthesis coverage: missing/unverified L2 schedule-34-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-65

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-66

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-67

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-68

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-69

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-70

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-71

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-72

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-73

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-74

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-75

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-76

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-77

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-78

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-79

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-80

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-81

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-82

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-83

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-84

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-85

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-86

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-87

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-88

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-89

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-90

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-91

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-92

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-93

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-94

synthesis coverage: missing/unverified L2 schedule-34-part-5

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-95

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-96

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-97

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-98

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-99

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-100

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-101

synthesis coverage: missing/unverified L2 schedule-34-part-6

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-102

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-103

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-104

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-105

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-106

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-107

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-108

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-109

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-110

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-111

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-112

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-113

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-114

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-115

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-116

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-117

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-118

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-119

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-120

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-121

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-122

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-123

synthesis coverage: missing evaluation uk:uksi/2012/1916#schedule-34-paragraph-124

Instrument tier unavailable

Change history as published

Reg. 32 revoked (20.8.2013) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(1), 35

Reg. 43A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 19

Reg. 51A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 35

Reg. 52A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 38

Reg. 53A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 41

Reg. 60B omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 50

Reg. 70 omitted (31.12.2020) by virtue of The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 79; 2020 c. 1, Sch. 5 para. 1(1)

Regs. 81-88 omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 65 · repeated 8×

Reg. 91 omitted (31.12.2020) by virtue of S.I. 2019/775, reg. 90B (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 67)

Reg. 94A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 66

Reg. 111 omitted (31.12.2020) by virtue of The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 103; 2020 c. 1, Sch. 5 para. 1(1)

Reg. 139 omitted (31.12.2020) by virtue of The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 122; 2020 c. 1, Sch. 5 para. 1(1)

Reg. 210 omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 98

Reg. 247A omitted (31.3.2026) by virtue of The Human Medicines (Amendment) Regulations 2026 (S.I. 2026/381), regs. 1(2), 10

Reg. 255A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 109(a)

Reg. 255B omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 109(b)

Reg. 255C omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 109(c)

Reg. 257A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 112

Reg. 257B omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 113

Sch. 11 para. 31 omitted (31.12.2020) by virtue of S.I. 2019/775, reg. 63(9) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 46(e))

Sch. 11 para. 34 omitted (31.12.2020) by virtue of S.I. 2019/775, reg. 63(9) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 46(e))

Sch. 11 para. 35 omitted (31.12.2020) by virtue of S.I. 2019/775, reg. 63(9) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 46(e))

Sch. 11 para. 37 omitted (31.12.2020) by virtue of S.I. 2019/775, reg. 63(9) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 46(e))

Sch. 11 para. 38 omitted (31.12.2020) by virtue of S.I. 2019/775, reg. 63(9) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 46(e))

Sch. 24 para. 18A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 142(d)

Sch. 33 para. 1 omitted (31.12.2020) by virtue of The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 178; 2020 c. 1, Sch. 5 para. 1(1)

Sch. 33 para. 2 omitted (31.12.2020) by virtue of The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 178; 2020 c. 1, Sch. 5 para. 1(1)

Sch. 33 paras. 5-10 omitted (31.12.2020) by virtue of The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 178 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 140); 2020 c. 1, Sch. 5 para. 1(1) · repeated 6×

Sch. 33A para. 29A omitted (1.1.2025) by virtue of The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024 (S.I. 2024/832), regs. 1(1), 145

Sch. 34 para. 78 revoked (1.4.2022) by The Medicines and Healthcare Products Regulatory Agency Trading Fund (Revocation) Order 2022 (S.I. 2022/90), art. 1, Sch.

Sch. 34 para. 85 revoked (E.) (7.12.2015) by The National Health Service (General Medical Services Contracts) Regulations 2015 (S.I. 2015/1862), reg. 1(2), Sch. 5 (with reg. 2)

Sch. 34 para. 87 revoked (E.) (7.12.2015) by The National Health Service (Personal Medical Services Agreements) Regulations 2015 (S.I. 2015/1879), reg. 1(2), Sch. 4 (with regs. 2, 88)

Pending effects amendments not yet applied to this text

reg. 38 heading words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 29(2) · Effective date unknown

reg. 149 heading word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 131(2) · Effective date unknown

Pt. 8 omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 132 · Effective date unknown

reg. 210A heading words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 175(2) · Effective date unknown

reg. 196 and cross-heading substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 156 · Effective date unknown

Show all 200

Pt. 12A omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 197 · Effective date unknown

reg. 3(12)(d)(ii) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 5(2)(b) · Effective date unknown · reg. 3

reg. 3(12)(d)(iv) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 5(2)(c) · Effective date unknown · reg. 3

reg. 3(15)(b) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 5(3)(b) · Effective date unknown · reg. 3

reg. 3(15)(d) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 5(3)(c) · Effective date unknown · reg. 3

reg. 5(1)(b) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 7(2) · Effective date unknown · reg. 5

reg. 5(2)(b) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 7(3)(a) · Effective date unknown · reg. 5

reg. 5(2)(d) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 7(3)(b) · Effective date unknown · reg. 5

reg. 5(3)(b) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 7(4)(a) · Effective date unknown · reg. 5

reg. 5(3)(d) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 7(4)(b) · Effective date unknown · reg. 5

reg. 5(4)(b) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 7(5) · Effective date unknown · reg. 5

reg. 5(5)(b) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 7(6)(a) · Effective date unknown · reg. 5

reg. 5(5)(d) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 7(6)(b) · Effective date unknown · reg. 5

reg. 6(3)(b) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 9(a) · Effective date unknown · reg. 6

reg. 6(4) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 9(b) · Effective date unknown · reg. 6

reg. 6(5) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 9(b) · Effective date unknown · reg. 6

reg. 8(1) words inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 10(3)(a) · Effective date unknown

reg. 8(1) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 10(3)(d) · Effective date unknown

reg. 17(1)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 14(2) · Effective date unknown · reg. 17

reg. 17(3)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 14(3) · Effective date unknown · reg. 17

reg. 17(4) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 14(4) · Effective date unknown · reg. 17

reg. 17(5) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 14(5) · Effective date unknown · reg. 17

reg. 18(1)(c) words omitted by virtue of S.I. 2019/775, reg. 15(2)(c) (as amended) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 2 · Effective date unknown · reg. 18

reg. 18(6) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 15(3) · Effective date unknown · reg. 18

reg. 18(7) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 15(4) · Effective date unknown · reg. 18

reg. 19(1)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 17(2) · Effective date unknown · reg. 19

reg. 19(6) inserted by S.I. 2019/775, reg. 17(4) (as inserted) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 3 · Effective date unknown · reg. 19

reg. 26(5)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 21 · Effective date unknown · reg. 26

reg. 31(5)(a) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 24(3) · Effective date unknown · reg. 31

reg. 36(4)-(7) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 27 · Effective date unknown · reg. 36

reg. 37(4)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 28(2)(a) · Effective date unknown · reg. 37

reg. 37(5)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 28(3) · Effective date unknown · reg. 37

reg. 37(6)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 28(4) · Effective date unknown · reg. 37

reg. 38(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 29(3) · Effective date unknown · reg. 38

reg. 38(3)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 29(3) · Effective date unknown · reg. 38

reg. 42(1) word substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 31(2) · Effective date unknown · reg. 42

reg. 42(4) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 31(3) · Effective date unknown · reg. 42

reg. 43(1) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(2) · Effective date unknown · reg. 43

reg. 43(5)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(3) · Effective date unknown · reg. 43

reg. 43(6)(b) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(4)(b) · Effective date unknown · reg. 43

reg. 43(7)(b)(i) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(5)(a)(i) · Effective date unknown · reg. 43

reg. 43(7)(b)(ii) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(3) · Effective date unknown · reg. 43

reg. 43(7)(c)(vii) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(5)(b) · Effective date unknown · reg. 43

reg. 43(8)(8A) substituted for reg. 43(8) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(6) · Effective date unknown · reg. 43

reg. 43(10) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(7) · Effective date unknown · reg. 43

reg. 43(11) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(7) · Effective date unknown · reg. 43

reg. 43(13) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(8) · Effective date unknown · reg. 43

reg. 43(15) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 33(9) · Effective date unknown · reg. 43

reg. 43A omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 34 · Effective date unknown · reg. 43A

reg. 44(2)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 35(2)(a) · Effective date unknown · reg. 44

reg. 44(2)(c) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 35(2)(b) · Effective date unknown · reg. 44

reg. 44(5)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 35(3) · Effective date unknown · reg. 44

reg. 44(5)(e) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 35(4)(a) · Effective date unknown · reg. 44

reg. 44(6)(e) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 35(5)(b) · Effective date unknown · reg. 44

reg. 45(1) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 36(2) · Effective date unknown · reg. 45

reg. 45(2)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 36(3) · Effective date unknown · reg. 45

reg. 45A(1)(a)(i)(ii) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 38(2)(a) · Effective date unknown · reg. 45A

reg. 45A(1)(b)(i) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 38(2)(b)(i) · Effective date unknown · reg. 45A

reg. 45A(1)(b)(ii) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 38(2)(b)(ii) · Effective date unknown · reg. 45A

reg. 45A(1)(b)(iii) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 38(2)(b)(iii) · Effective date unknown · reg. 45A

reg. 45A(2)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 38(3)(a) · Effective date unknown · reg. 45A

reg. 45A(2)(c) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 38(3)(b) · Effective date unknown · reg. 45A

reg. 45E(3)(b)(i) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 40(a) · Effective date unknown · reg. 45E

reg. 45E(3)(d)(iii) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 40(b) · Effective date unknown · reg. 45E

reg. 45M(2)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 42(2) · Effective date unknown · reg. 45M

reg. 45O(1) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 44(2) · Effective date unknown · reg. 45O

reg. 45O(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 44(3) · Effective date unknown · reg. 45O

reg. 45O(3) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 44(4)(a) · Effective date unknown · reg. 45O

reg. 45O(3)(c) word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 44(4)(c)(i) · Effective date unknown · reg. 45O

reg. 45O(3)(c)(ii) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 44(4)(c)(ii) · Effective date unknown · reg. 45O

reg. 45O(3)(c)(iii) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 44(4)(c)(iii) · Effective date unknown · reg. 45O

reg. 45O(4)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 44(5)(a) · Effective date unknown · reg. 45O

reg. 45O(4)(b)(i) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 44(5)(b) · Effective date unknown · reg. 45O

reg. 46(2)(b) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 45(2)(b) · Effective date unknown · reg. 46

reg. 46(2)(d) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 45(2)(c) · Effective date unknown · reg. 46

reg. 46(6)(a) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 45(4)(a) · Effective date unknown · reg. 46

reg. 46(6)(b) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 45(4)(b) · Effective date unknown · reg. 46

reg. 46(6)(d) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 45(4)(c) · Effective date unknown · reg. 46

reg. 46(7)(b) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 45(5) · Effective date unknown · reg. 46

reg. 47(6) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 46(3) · Effective date unknown · reg. 47

reg. 48(2) words inserted by S.I. 2019/775, reg. 47(2)(a) (as amended) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 4(a) · Effective date unknown · reg. 48

reg. 48(2) words omitted by virtue of S.I. 2019/775, reg. 47(2)(d) (as amended) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 4(b)(i) · Effective date unknown · reg. 48

reg. 48(2) words inserted by S.I. 2019/775, reg. 47(2)(d) (as amended) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 4(b)(ii) · Effective date unknown · reg. 48

reg. 49(1A) inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 48(3) · Effective date unknown · reg. 49

reg. 49(3) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 48(4) · Effective date unknown · reg. 49

reg. 49(9) inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 48(6) · Effective date unknown · reg. 49

reg. 50(4) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 49(2) · Effective date unknown · reg. 50

reg. 51 substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 56 · Effective date unknown · reg. 51

reg. 51(9) words inserted by S.I. 2019/775, reg. 56 (as amended) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 5 · Effective date unknown · reg. 51

reg. 52(1)(a)(i)(ii) and words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 57(2) · Effective date unknown · reg. 52

reg. 52(1)(b) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 57(3) · Effective date unknown · reg. 52

reg. 52(2) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 57(4) · Effective date unknown · reg. 52

reg. 52(3) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 57(5)(a) · Effective date unknown · reg. 52

reg. 53(1) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 58(2) · Effective date unknown · reg. 53

reg. 53(2)-(2C) substituted for reg. 53(2) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 58(3) · Effective date unknown · reg. 53

reg. 53(2)(a) substituted by S.I. 2019/775, reg. 58(3) (as amended) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 6(2) · Effective date unknown · reg. 53

reg. 53(3) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 58(4)(a) · Effective date unknown · reg. 53

reg. 53(3) words substituted by S.I. 2019/775, reg. 58(4)(a) (as substituted) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 6(3) · Effective date unknown · reg. 53

reg. 55(1)(a) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 60(2) · Effective date unknown · reg. 55

reg. 55(2) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 60(3) · Effective date unknown · reg. 55

reg. 58(6) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 62(3) · Effective date unknown · reg. 58

reg. 58(7) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 62(3) · Effective date unknown · reg. 58

reg. 59(3) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 65(2) · Effective date unknown · reg. 59

reg. 59(3A)(3B) inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 65(3) · Effective date unknown · reg. 59

reg. 59(5) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 65(6) · Effective date unknown · reg. 59

reg. 60(9) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 66 · Effective date unknown · reg. 60

reg. 60A inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 67 · Effective date unknown · reg. 60A

reg. 61(6) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 68(3) · Effective date unknown · reg. 61

reg. 61(7)-(7B) substituted for reg. 61(7) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 68(4) · Effective date unknown · reg. 61

reg. 61(13) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 68(5) · Effective date unknown · reg. 61

reg. 64(4)(d) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 69 · Effective date unknown · reg. 64

reg. 66(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 74 · Effective date unknown · reg. 66

reg. 68(7) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 77(3)(b) · Effective date unknown · reg. 68

reg. 68(9) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 77(5) · Effective date unknown · reg. 68

reg. 71(1)(b) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 80(2)(b)(i) · Effective date unknown · reg. 71

reg. 71(1)(b) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 80(2)(b)(ii) · Effective date unknown · reg. 71

reg. 72(1) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 81 · Effective date unknown · reg. 72

reg. 73(5C) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 82(3) · Effective date unknown · reg. 73

reg. 76(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 84 · Effective date unknown · reg. 76

reg. 77 word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 85 · Effective date unknown · reg. 77

reg. 78 word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 86 · Effective date unknown · reg. 78

reg. 79 omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 88 · Effective date unknown · reg. 79

reg. 80(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 89(3) · Effective date unknown · reg. 80

reg. 80(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 89(4) · Effective date unknown · reg. 80

reg. 80(c) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 89(5) · Effective date unknown · reg. 80

reg. 81-94 omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 90 · Effective date unknown

reg. 94A omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 91 · Effective date unknown · reg. 94A

reg. 95 word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 92(2) · Effective date unknown · reg. 95

reg. 95(c) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 92(3) · Effective date unknown · reg. 95

reg. 95(d) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 92(3) · Effective date unknown · reg. 95

reg. 96(1) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 93(2)(a) · Effective date unknown · reg. 96

reg. 96(1)(b) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 93(2)(b) · Effective date unknown · reg. 96

reg. 96(1)(c) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 93(2)(b) · Effective date unknown · reg. 96

reg. 96(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 93(3) · Effective date unknown · reg. 96

reg. 97 words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 94(2)(a) · Effective date unknown · reg. 97

reg. 98(2)(a) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 95 · Effective date unknown · reg. 98

reg. 99(1) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 96(2) · Effective date unknown · reg. 99

reg. 99(2) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 96(3) · Effective date unknown · reg. 99

reg. 101(1) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 97(2) · Effective date unknown · reg. 101

reg. 101(3) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 97(3) · Effective date unknown · reg. 101

reg. 103(4) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 99(2) · Effective date unknown · reg. 103

reg. 104(5) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 100 · Effective date unknown · reg. 104

reg. 104(6) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 100 · Effective date unknown · reg. 104

reg. 108(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 101 · Effective date unknown · reg. 108

reg. 110(7) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 102(2) · Effective date unknown · reg. 110

reg. 110(10) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 102(3) · Effective date unknown · reg. 110

reg. 116(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 107 · Effective date unknown · reg. 116

reg. 125(5)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 110 · Effective date unknown · reg. 125

reg. 127(3) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 113 · Effective date unknown · reg. 127

reg. 128(3) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 114 · Effective date unknown · reg. 128

reg. 130(7) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 116(3) · Effective date unknown · reg. 130

reg. 130(8) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 116(4) · Effective date unknown · reg. 130

reg. 130(9) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 116(5) · Effective date unknown · reg. 130

reg. 130(10)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 116(6) · Effective date unknown · reg. 130

reg. 130(12) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 116(7) · Effective date unknown · reg. 130

reg. 130(13) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 116(7) · Effective date unknown · reg. 130

reg. 133(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 118 · Effective date unknown · reg. 133

reg. 135(7)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 119(2) · Effective date unknown · reg. 135

reg. 135(8) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 119(3) · Effective date unknown · reg. 135

reg. 135(9)(b) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 119(4) · Effective date unknown · reg. 135

reg. 136(1)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 120(2) · Effective date unknown · reg. 136

reg. 140(1)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 123 · Effective date unknown · reg. 140

reg. 142(5C) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 125 · Effective date unknown · reg. 142

reg. 144 words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 127 · Effective date unknown · reg. 144

reg. 146(2) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 129 · Effective date unknown · reg. 146

reg. 149(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 131(3) · Effective date unknown · reg. 149

reg. 149(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 131(4) · Effective date unknown · reg. 149

reg. 149(c) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 131(5) · Effective date unknown · reg. 149

reg. 159(1) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 133(b) · Effective date unknown · reg. 159

reg. 164(2)(b) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 134(b) · Effective date unknown · reg. 164

reg. 168(8)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 135(a) · Effective date unknown · reg. 168

reg. 168(8)(b) substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 135(b) · Effective date unknown · reg. 168

reg. 169(9)(a) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 136 · Effective date unknown · reg. 169

reg. 171(2)(c) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 137 · Effective date unknown · reg. 171

reg. 173(c) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 138 · Effective date unknown · reg. 173

reg. 177(1) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(2)(a) · Effective date unknown · reg. 177

reg. 177(1) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(2)(b) · Effective date unknown · reg. 177

reg. 177(1)(a) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(2)(c) · Effective date unknown · reg. 177

reg. 177(1)(c) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(2)(d) · Effective date unknown · reg. 177

reg. 177(2)(a) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(3)(b) · Effective date unknown · reg. 177

reg. 177(2)(c) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(3)(c) · Effective date unknown · reg. 177

reg. 177(3)(a) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(4)(b) · Effective date unknown · reg. 177

reg. 177(3)(c) and word omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(4)(c) · Effective date unknown · reg. 177

reg. 177(4) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(5) · Effective date unknown · reg. 177

reg. 177(5) words omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 139(6) · Effective date unknown · reg. 177

reg. 177(5) words substituted by S.I. 2019/775, reg. 139(6)(a) (as substituted) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 8 · Effective date unknown · reg. 177

reg. 177(5) word omitted by virtue of S.I. 2019/775, reg. 139(6)(b) (as substituted) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 8 · Effective date unknown · reg. 177

reg. 177(5) words inserted by S.I. 2019/775, reg. 139(6)(c) (as substituted) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 8 · Effective date unknown · reg. 177

reg. 177(5) word omitted by virtue of S.I. 2019/775, reg. 139(6)(d) (as substituted) by The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 Sch. 1 para. 8 · Effective date unknown · reg. 177

reg. 181 omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 141 · Effective date unknown · reg. 181

reg. 182(2)(a) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 142(2) · Effective date unknown · reg. 182

reg. 182(3) words inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 142(3) · Effective date unknown · reg. 182

reg. 186(1)(a) word inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 145(a) · Effective date unknown · reg. 186

reg. 186(1)(c)-(e) omitted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 145(b) · Effective date unknown · reg. 186

reg. 187(1) words substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 reg. 147(2) · Effective date unknown · reg. 187

Provenance

Every claim the system makes about this text is traceable to these identifiers.

Instrument: uk:uksi/2012/1916
Part: PART 1 General
Version: 257dcf45b9193c8bf67392a8…
Content hash: sha256 58abd4677be4e90769da10c7…
Source: legislation.gov.uk/uksi/2012/1916